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Huntingtin-Encoded Polyglutamine Expansions
Form Amyloid-like Protein Aggregates
In Vitro and In Vivo
Eberhard Scherzinger,* Rudi Lurz,* mutant forms of huntingtin have been shown to be ex-
pressed at similar levels in the central nervous systemMark Turmaine,³ Laura Mangiarini,²
and are also present in peripheral tissues (Trottier et al.,Birgit Hollenbach,* Renate Hasenbank,*
1995a). Within the brain, huntingtin was found pre-Gillian P. Bates,² Stephen W. Davies,³
dominantly in neurons and was present in cell bodies,Hans Lehrach,* and Erich E. Wanker*
dentrites, and also in the nerve terminals. Immunohisto-*Max-Planck-Institut fuÈ r Molekulare Genetik
chemistry, electron microscopy, and subcellular frac-D-14195 Berlin (Dahlem)
tionations have shown that huntingtin is primarily a cyto-Germany
solic protein, a fraction of which is associated with²Division of Medical and Molecular Genetics
vesicles and/or microtubules, suggesting that it plays aUnited Medical and Dental Schools
functional role in cytoskeletal anchoring or transport ofGuy's Hospital
vesicles (DiFiglia et al., 1995; Gutekunst et al., 1995;London SE1 7EH
Sharp et al., 1995) Huntingtin has also been detected inUnited Kingdom
the nucleus (Hoogeveen et al., 1993; de Rooij et al.,³Department of Anatomy and Developmental
1996), suggesting that transcriptional regulation cannotBiology
be ruled out as a possible function of this protein.University College London
In addition to HD, CAG/polygln expansions have beenLondon WC1E6BT
found in at least six other inherited neurodegenerativeUnited Kingdom
disorders including spinal and bulbar muscular atrophy
(SBMA), dentatorubral pallidoluysian atrophy (DRPLA),
and the spinocerebellar ataxia (SCA) types 1, 2, 3, andSummary
6 (referenced in Bates et al., 1997). The normal and
expanded size ranges are comparable with the excep-The mechanism by which an elongated polyglutamine
tion of SCA6 in which the expanded alleles are smallersequence causes neurodegeneration in Huntington's
and the mutation is likely to act by a different route.disease (HD) is unknown. In this study, we show that
However, in all cases the CAG repeat is located withinthe proteolytic cleavage of a GST-huntingtin fusion
the coding region and is translated into a stretch ofprotein leads to the formation of insoluble high molec-
polygln residues. Although the proteins harboring theular weight protein aggregates only when the polyglu-
polygln sequences areunrelated and mostly of unknowntamine expansion is in the pathogenic range. Electron
function, it is likely that the mutations act through a
micrographs of these aggregates revealed a fibrillar or
similar mechanism. Without exception, these proteins
ribbon-like morphology, reminiscent of scrapie prions
are widely expressed and generally localized to theand b-amyloid fibrils in Alzheimer's disease. Sub-
cytoplasm. However, despite overlapping expressioncellular fractionation and ultrastructural techniques
patterns in brain, the neuronal cell death is relatively
showed the in vivo presence of these structures in the
specific and can differ markedly (Ross, 1995), indicating
brains of mice transgenic for the HD mutation. Our in
that additional factors are needed to convey the specific
vitro model will aid in an eventual understanding of
patterns of neurodegeneration.
the molecular pathology of HD and the development Several investigators have proposed that HD is
of preventative strategies. caused by a toxic gain of function, which in turn is
caused by abnormal protein±protein interactions related
to the elongated polygln. It is possible that the binding
Introduction of a protein to the polygln region could either confer a
new property on huntingtin or alter its normal interac-
Huntington's disease (HD) is an autosomal dominant tions, causing selective cell death either through the
progressive neurodegenerative disorder characterized specific expression patterns of the interacting protein
by personality changes, motor impairment and subcorti- or through the selective vulnerability of certain cells. To
cal dementia (Harper, 1991). It is associated with a selec- date, four potential huntingtin-interacting proteins have
tive neuronal cell death occurring primarily in the cortex been isolated: HAP1 (Li et al., 1995), GAPDH (Burke
and striatum (Vonsattel et al., 1985). The disorder is et al., 1996), HIP2 (Kalchman et al., 1996), and HIP-I
caused by a CAG/polyglutamine (polygln) repeat expan- (Kalchman et al., 1997; Wanker et al., 1997). However,
sion in the first exon of a gene encoding a large z350 an involvement of these proteins in the selective neuro-
kDa protein of unknown function (Huntington's Disease pathology has not been demonstrated. A gain-of-func-
Collaborative Research Group, 1993). The CAG repeat tion mechanism has been supported by the identifica-
is highly polymorphic and varies from 6 to 39 repeats tion of an antibody that specifically reacts with the
on chromosomes of unaffected individuals and from 36 pathogenic polygln expansions (Trottier et al., 1995b).
to 180 repeats on HD chromosomes (Rubinsztein et al., This indicates that upon expansion into the pathogenic
1996; Sathasivam et al., 1997). The majority of adult range, a polygln sequence may undergo a conforma-
onset cases have expansions ranging from 40 to 55 tional change. Poly-L-glutamines form pleated sheets
units, whereas expansions of 70 and above invariably of b strands held together by hydrogen bonds between
their amides (Perutz et al., 1994). It was proposed thatcause the juvenile form of the disease. The normal and
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the expanded glutamine repeats in huntingtin may func-
tion as polar zippers, joining protein molecules together
(Perutz, 1996). In the long run, this could result in the
precipitation of huntingtin protein in specific neurons,
causing the observed selective neuronal loss. Thus, the
mechanism underlying HD would be similar to scrapie,
Creutzfeldt-Jakob, or Alzheimer's disease, in which
b-sheet secondary structures lead to the formation of
toxic protein aggregates in selective neurons (Caughey
and Chesebro, 1997).
Recently, lines of mice (R6) that are transgenic for the
HD mutation have been generated (Mangiarini et al.,
1996). In these mice, exon 1 of the human HD gene
carrying CAG repeat expansions of 115±156 units is
expressed under the control of the human HD promoter.
It has been demonstrated that the transgenic animals
exhibit a progressive neurological phenotype that ex-
hibits many of the motor and nonmotor features of HD.
The phenotype includes a resting tremor; irregular
gait; rapid, abrupt shuddering movements; stereotypic
grooming movements; and epileptic seizures. Coinci-
dent with the onset of the movement disorder, the mice
show a progressive weight loss. Neuropathological
analysis has shown a reduction in brain weight (which
precedes that in body weight) and the presence of
neuronal intranuclear inclusions (NIIs) predating any evi-
dence of neuronal dysfunction (Davies et al., 1997 [this
issue of Cell]). The NIIs are immunoreactive for N-termi-
nal huntingtin antibodies that detect the transgene pro-
tein and for ubiquitin but do not contain the endogenous
Figure 1. SDS±PAGE Analysis of Purified GST and GST-HD Fusionmouse huntingtin. At the ultrastructural level, a solitary
Proteins
intranuclear inclusion appears as a roughly circular pale
(a) Aliquots (15 ml) of eluates from the glutathione agarose column
structure of a fine granular nature with occasional fila- were subjected to 12.5% SDS±PAGE and analyzed by staining with
mentous structures and devoid of a membrane. In addi- Coomassie blue R. Lanes 1±6 contain GST, GST-HD20, -HD30,
tion, the neurons invariably have indentations of the -HD51, -HD83, and -HD122, respectively; lane M contains molecular
mass standards.nuclear membrane and an apparent increase in the den-
(b) Proteins were transferred to nitrocellulose and probed with anti-sity and clustering of nuclear pores. All three of these
HD1 antibody. Arrows mark the origin of electrophoresis.ultrastructural nuclear changes have previously been
reported in EM studies from HD patients (Tellez-Nagel
et al., 1974; Roizin et al., 1979; Roos and Bots, 1983).
the expression of GST-HD fusion proteins in E. coli.In this report, we have used exon 1 of the HD gene
DNA fragments containing CAG repeats in the normalwith expanded CAG repeats for the production of gluta-
(CAG)20±33 and expanded (CAG)37±130 range were clonedthione S-transferase (GST)-HD fusion proteins in E. coli.
into pGEX-5X-1 (Pharmacia), and the resulting plasmidsThe recombinant proteins were purified under native
expressing fusion proteins with 20 (GST-HD20), 30conditions by affinity chromatography (Smith and John-
(-HD30), 51 (-HD51), 83 (-HD83), and 122 (-HD122) gluta-son, 1988). Site-specific proteolysis of a GST-HD51 fu-
mines, respectively, were used for protein purification.sion protein with a polygln expansion in the pathological
After induction with IPTG, the resulting proteins wererange (51 glutamines) resulted in the formation of high
purified under native conditions by affinity chromatogra-molecular weight protein aggregates with a fibrillar or
phy on glutathione agarose. SDS±PAGE of the purifiedribbon-like morphology. The filaments, which were not
GST-HD20, -HD30, -HD51, -HD83, and -HD122 proteinsproduced by proteolysis of shorter fusion proteins (20
revealed major bands of 42, 45, 50, 65, and 75 kDa,or 30 glutamines), were similar to scrapie prions and
respectively (Figure 1a). These bands were also de-b-amyloid-like fibrils in Alzheimer's disease, and also
tected when the various protein fractions were sub-resemble those detected by electron microscopy in the
jected to immunoblot analysis using the affinity-purifiedNIIs of mice trangenic for the HD mutation.
anti-huntingtin antibody HD1 (Figure 1b, lanes 2±6). HD1
specifically detects the GST-HD fusion proteins on im-
munoblots, whereas theGST tag alone is not recognizedResults
(Figure 1b, lane 1). All recombinant proteins migrated
at a size corresponding nearly to that predicted fromPurification of GST-HD Fusion Proteins
Containing Expanded Polyglns their amino acid sequence. Interestingly, an additional
high molecular weight band that remains at the top ofExon 1 of the HD gene was isolated from genomic phage
clones, derived from the normal and expanded alleles the gel was consistently detected in the protein fractions
with the longest polyglns (83 and 122 residues; Figuresof an HD patient (Sathasivam et al., 1997), and used for
Huntingtin Protein Aggregates
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Figure 2. Structure of GST-HD Fusion Proteins
The amino acid sequence corresponding to exon 1 of huntingtin is boxed. Arrows labeled (Xa) and (T) indicate cleavage sites for factor Xa
and trypsin, respectively.
1a and 1b, lanes 5 and 6). This band was most prominent trypsin cleavage products have been applied. On the
cellulose acetate filter, only the cleavage products ofon the immunoblots but was also clearly detectable in
the Coomassie-stained gel. This immunoreactive mate- GST-HD51 were detected by the anti-HD1 antibody, in-
dicating the formationof insoluble high molecularweightrial was often still present at the bottom of the loading
slots, even after the samples had been boiled for 5 min protein aggregates. In contrast, all of the uncleaved
GST-HD fusion proteins and their digestion productsin the presence of 2% SDS and 6 M urea prior to loading.
were detected on the nitrocellulose control filter.
Proteolytic Cleavage of GST-HD Fusion Proteins
Huntingtin Proteins Containing Expanded PolyglnsContaining Expanded Polyglns
in the Pathological Range AggregateIt has been shown previously that the solubility of certain
to Amyloid-Like Birefringent Fibrilsproteins can be enhanced by the addition of the GST
Electron microscopy of negatively stained GST-HD51tag (Smith and Johnson, 1988), and it was therefore of
fractions showed oligomeric particles with diameters ofinterest to determine whether the removal of the GST
6±7 nm (Figure 4a); no higher ordered aggregates weretag by proteolytic cleavage would have an effect on
observed. In contrast, protein fractions obtained by pro-the solubility of the polygln-containing fusion proteins.
teolytic cleavage of GST-HD51 showed numerous clus-Potential factor Xa and trypsin cleavage sites within the
ters of high molecular weight fibrils and ribbon-likeGST-HD fusion proteins are shown in Figure 2. Factor
structures (Figures 4b±4e), reminiscent of purified amy-Xa cleaves between the GST tag and the HD exon 1
loids (Prusiner et al., 1983). The fibrils obtained afterprotein, whereas trypsin removes an additional 15 amino
digestion with factor Xa showed a diameter of 10±12acids from the N terminus and a single proline from the
nm, and their length varied from 100 nm up to severalC terminus, both proteases leaving the polygln repeat
micrometers (Figures 4b and 4c). In the trypsin-treatedintact. The GST-HD20, -HD30, and -HD51 proteins were
samples, ribbon-like structures formed by lateral aggre-digested with trypsin under conditions designed to re-
gation of fibrils with a diameter of 7.7 nm were observedmove the GST tag from the fusion protein without it
(Figures 4d and 4e). After treatment with factor Xa orbeing totally degraded. After cleavage, proteins were
limited digestion with trypsin, clots of small particlesdenatured by boiling in the presence of 2% SDS and
were frequently detected on one or both ends of theanalyzed by SDS±PAGE and immunoblotting using
fibrils (Figures 4b±4d). These clots of varying sizes andthe anti-HD1 antibody. GST-HD20 and -HD30 cleavage
shapes were not seen when GST-HD51 was digestedyielded products migrating in a 12.5% gel at approxi-
with trypsin under conditions in which the GST tag ismately 30and 33kDa, respectively. In contrast, cleavage
totally degraded (Figure 4e), indicating that they containof GST-HD51 resulted in the formation of two protein
GST. In strong contrast to GST-HD51, the GST-HD20products migrating at approximately 37 and 60 kDa, and
and -HD30 proteins did not show any tendency to forman additional weak immunoreactive band on the bottom
ordered high molecular weight structures, either with orof the loading slots was also detected (Figure 3a). This
without protease treatment (Figure 4f).high molecular weight bandwas more pronounced when
The insoluble protein aggregates formed by proteo-GST-HD51 was digested with trypsin under conditions
lytic cleavage of GST-HD51 were isolated by centrifuga-in which the GST tag was totally degraded (Figure 3b).
tion and stained with Congo red (Caputo et al., 1992).However, with proteins GST-HD20 and -HD30, this longer
After staining, the protein aggregates on the glass slidesexposure to trypsin produced the same cleavage prod-
were red, indicating that they had bound the dye (Figureucts as the ones seen in Figure 3a, and the high molecu-
5a), and when examined under polarized light, a greenlar weight products were not observed. Similar results
color and birefringence were detected (Figures 5b andwere obtained with factor Xa protease and endopro-
5c). These staining characteristics were similar to thoseteinases Arg-C and Lys-C (data not shown).
observed for prions (Prusiner et al., 1983) and amyloidsWe have developed a simple and sensitive filter assay
(Caputo et al., 1992).to detect the formation of high molecular weight insolu-
ble protein aggregates. This assay is based on the find-
ing that the SDS-insoluble protein aggregates obtained Huntingtin Proteins Containing Expanded
Polyglns Form Amyloid-Like Proteinby proteolytic cleavage of GST-HD51 are retained on a
cellulose acetate filter, whereas the soluble cleavage Aggregates In Vivo
To determine whether the amyloid-like protein aggre-products of GST-HD20 and GST-HD30 are not. Figure
3c shows immunoblots of cellulose acetate and nitro- gates formed by proteolytic cleavage of GST-HD51 in
vitro are also present in vivo, nuclear protein fractionscellulose membranes to which the native GST-HD20,
-HD30, and -HD51 proteins and their factor Xa and of brain and kidney were prepared from mice transgenic
Cell
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Figure 3. Site-Specific Proteolysis of GST-HD Fusion Proteins with Trypsin and Factor Xa
(a and b) Tryptic digestions were performed at 378C for 3 (a) or 16 hr (b). Native proteins and their cleavage products were subjected to 12.5%
SDS±PAGE, blotted onto nitrocellulose membranes, and probed with anti-HD1 antibody. Arrows mark the origin of electrophoresis.
(c) Purified fusion proteins and their factor Xa and trypsin cleavage products were analyzed using the filter retardation assay. The proteins
retained by the cellulose acetate and nitrocellulose membranes were detected by incubation with the anti-HD1 antibody.
for the HD mutation (line R6/2) and littermate controls To examine whether the NIIs containing the proteins
huntingtin and ubiquitin (Davies et al., 1997) have a fi-(Mangiarini et al., 1996; Davies et al., 1997). The protein
extracts wereanalyzed by SDS±PAGE and Western blot- brous composition, an ultrastructural analysis was per-
formed. An electron micrograph of a NII from a 17 monthting using the anti-HD1 antibody (Figure 6a). Strikingly,
this antibody detected a prominent high molecular old R6/5 homozygous mouse is shown in Figure 6c. This
NII (large arrow) contains high molecular weight fibrousweight band in the nuclear fraction (N) prepared from
R6/2 transgenic brain, very similar to the high molecular structures that were clearly differentiated from the sur-
rounding chromatin. The filaments were randomly ori-weight band obtained by proteolytic cleavage of GST-
HD51 (Figure 3b). No such immunoreactive band was ented, 5±10 nm in diameter, and often measured up to
250 nm in length (small arrows). These structures differdetected in the nuclear fraction of brain from the lit-
termate control, and it was also absent from the corre- from those previously reported in the NIIs seen in hemi-
zygous R6/2 mice that were far more granular in compo-sponding cytoplasmic fractions (C). A small amount of
high molecular weight material was also detected in the sition, with individual filamentous structures being more
difficult to distinguish (Davies et al., 1997). R6/2 micenuclear fraction prepared from R6/2 transgenic kidney,
but was again absent from the cytoplasmic fraction. exhibit an earlier age of onset with a more rapid progres-
sion of the phenotype and do not survive beyond 13The purity of the nuclear and cytoplasmic fractions was
confirmed by Western blot analysis using the anti-Fos weeks (Mangiarini et al., 1996). It is possible that the
filamentous structures do not have time to form in theB and anti-GAPDH antibodies. Anti-Fos B detected the
transcription factor mainly in the nuclear fraction, and R6/2 mice.
the enzyme GAPDH was only seen in the cytoplasmic
fraction, as expected. The Western blot results were Discussion
reproduced using the cellulose acetate filter assay (Fig-
ure 6b). Using this assay, a 10- to 20-fold higher amount We have developed an in vitro system by which highly
stable amyloid-like protein aggregates can be formedof transgene protein was detected in the nuclear fraction
isolated from brain material, compared to that prepared under defined conditions by proteolytic cleavage of GST
fusion proteins corresponding to exon 1 of the HD genefrom kidney.
The formation of NIIs has been shown to precede and containing expandedpolygln sequences. The arrays
of fibrillar structures of varying sizes and shapes ob-the neuronal dysfunction that forms the basis of the
progressive neurological phenotype observed in the R6 served by electron microscopy clearly resemble those
of purified amyloids. Furthermore, the polarization mi-transgenic lines (Davies et al., 1997). These NIIs are
immunoreactive for both huntingtin and ubiquitin anti- croscopic properties of the fibrils stained with Congo
red arestrikingly similar to those described for amyloids.bodies and contain the transgene but not the endoge-
nous huntingtin protein. Therefore, Western blot analy- The green-gold birefringence of the amyloid-like fibrils
indicates that the polymers have common structuralsis using an anti-ubiquitin antibody was also performed
showing the same pattern of immunoreactivity as had features. Although the Congo red staining does not
determine conclusively whether the fibrils consist ofbeen observed with the anti-HD1 antibody (Figure 6a),
and indicating that the high molecular weight transgene b-pleated sheets, the method suggests that this is likely
in view of experience gained with other protein polymersprotein present in the nuclear fraction is ubiquitinated
(data not shown). (Caputo et al., 1992). However, it has been generally
Huntingtin Protein Aggregates
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Figure 4. Electron Micrographs of Native GST-HD Fusion Proteins and Their Factor Xa and Trypsin Cleavage Products
Purified GST fusion proteins were protease treated, negatively stained with uranyl acetate, and viewed by electron microscopy. The undigested
GST-HD51 molecules appear as a homogeneous population of small, round particles (a). Removal of the GST tag with factor Xa results in
the formation of amyloid-like fibrils and intermediate structures (b and c). After partial digestion (3 hr) of GST-HD51 with trypsin, the ribbons
are associated with terminal clots ([d], arrow), whereas prolonged digestion (16 hr) produces ribbons without attached clots (e). Removal of
the GST tag from GST-HD20 shows no evidence for the formation of defined structures (f).
accepted that naturally occuring mammalian protein ultracentrifugation that the recombinant protein, in addi-
tion to monomers, formed dimers and trimers, whereaspolymers that exhibit fibrillar structures and green bire-
fringence after Congo red staining should be classified wild-type CI2 was present only in the monomeric form
(Stott et al., 1995). It has been proposed that the polyglnas amyloids (Glenner, 1980).
It has been shown by X-ray diffraction studies that stretch functions as a polar zipper, joining proteins to-
gether. However, the hypothesis that glutamine repeatssynthetic peptides containing polyglns form b sheets
strongly held together by hydrogen bonds (Perutz et al., in proteins form b-pleated sheets and induce protein
aggregation by a mechanism similar to that observed1994). Because synthetic poly(L-glutamine) is insoluble
in water, a synthetic peptide with the sequence Asp2- in spongiform encephalopathy (TSE) diseases (Caughey
and Chesebro, 1997) could not be proven with this re-Gln15-Lys2 was used in that study. A stretch of 10 gluta-
mines was also inserted into the loop of chymotrypsin combinant protein. Most likely, the length of the polygln
sequence inserted into CI2 was too short.inhibitor-2 (CI2), and it was demonstrated by analytical
Figure 5. Birefringence of Protein Aggregates Formed by Proteolytic Cleavage of GST-HD51
The protein aggregates were stained with Congo red. (a) Bright field, 2003; (b) Polarized light, 2003; (c) Polarized light, 1003.
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Figure 7. Proposed Mechanism for the Formation of Amyloid-Like
Fibrils by Proteolytic Cleavage of GST-HD51
GST-HD51 molecules are represented as follows: zigzag line, elon-
gated polygln repeat forming a stable hairpin with b-sheet structure;
dotted line, N-terminal amino acids in the HD exon 1 protein con-
taining the factor Xa cleavage site (arrow) (undefined structure); thin
line, C-terminal amino acids in the HD exon 1 protein (undefined
structure); shaded symbol, the dimeric globule-like form of GST.
Prior to cleavage, the HD exon 1 protein is tightly bound to the GST
tag, preventing intermolecular interactions (1). Removal of the GST
tag with factor Xa renders the polygln repeat accessible, allowing the
formation of fibrils as seen by EM (3). During cleavage, intermediate
structures form through specific polygln interactions before com-
plete release of the GST tag has occurred (2). These intermediates
appear as clots under EM and are frequently seen at the terminals
of growing fibrils.
whereas the protein with 51 glutamines was soluble
and no fibrillar structures were detected by electron
microscopy (Figure 4a). This indicates that the critical
length of the polygln stretch in the fusion proteins lead-
ing to the formation of aggregates is greater than 51
Figure 6. Polygln-Containing Protein Aggregates Are Formed In
glutamines. However, when the GST tag, which is knownVivo
to enhance the solubility of many proteins (Smith and(a) Western blot analysis, after separation by 10% SDS±PAGE, of
Johnson, 1988), was cleaved by limited digestion withthe nuclear (N) and cytosolic (C) protein fractions prepared from
trypsin, the liberated HD exon 1 protein with 51 gluta-brain and kidney of an R6/2 hemizygous transgenic mouse and a
littermate control. Blots were probed with anti-HD1, anti-GAPDH, mines also started to form aggregates (Figure 3a) and
and anti-Fos B antibodies as indicated. the amount of these aggregates increased when the
(b) Detection of HD exon 1 protein aggregates formed in vivo using GST tag was totally degraded with trypsin (Figure 3b).
the cellulose acetate filter assay. The membrane was immuno-
This indicates that in the HD exon 1 protein 51 gluta-stained using the anti-HD1 antibody.
mines are sufficient to form aggregates, whereas 20 and(c) Ultrastructure of a NII. The presence of a NII in a striatal neuron
30 glutamines under the same conditions are not. Theof a 17 month old R6/5 homozygous mouse is shown. The NII is
indicated by the large arrow, and the fibrillar amyloid-like structures minimum critical length essential for the development
within the NII are indicated by two small arrows. The scale bar is of amyloid-like structures after removal of the GST tag
250 nm. is not known and has to be determined. However, pre-
liminary experiments in our laboratory suggest that the
Our studies with the GST-HD fusion proteins con- threshold for the formation of HD exon 1 protein aggre-
taining polygln sequences of varying lengths demon- gates is between 35 and 48 glutamines. This result is
strate that a certain length of the polygln stretch is nec- strikingly similar to the pathological threshold in HD,
essary for the formation of amyloid-like fibrils in vitro. SBMA, DRPLA, SCA1, SCA2, and SCA3. In all of these
When the purified fusion proteins were analyzed by neurodegenerative polygln diseases, unaffected indi-
SDS±PAGE, insoluble high molecular weight protein ag- viduals have not been described with a repeat length
gregates were only detected with the proteins con- greater than 40 glutamines. This suggests that the elon-
gation of the polygln repeat beyond a certain length maytaining 81 and 122 glutamines (Figures 1a and 1b),
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lead to a phase change. This could, for example, be a For the first time, our results raise the possibility that
HD, DRPLA, SBMA, SCA1, SCA2, and SCA3 are thechange from random coils to hydrogen-bonded hairpins
result of a toxic amyloid fibrillogenesis. Although thein the polygln stretch. Perutz (1996) proposed that elon-
detection of amyloid-like fibrils has not previously beengated polyglns might form stable hairpins when the
reported in these inherited diseases, our results stronglynumber of glutamines exceeds 41. He suggested that
suggest that polygln-containing polymers are also formedat a certain critical length of the polygln sequence, the
in vivo by their detection in a transgenic model of poly-loss of entropy during formation of the hairpin may be-
glutamine disease. The high molecular weight aggre-come negligible and the system would then become
gates were exclusively detected in the nuclear fractionstrongly stabilized by a gain of entropy due to the liber-
prepared from transgene brain material, which is in goodated water molecules. Our experimental results with the
agreement with the results of Davies et al. (1997), whoGST fusion proteins containing polygln sequences of
demonstrated the presence of the transgene proteinvarying lengths support this hypothesis. However,
and ubiquitin in neuronal intranuclear inclusions, fromwhether the polygln stretch in GST-HD51 has a hairpin
a time prior to the development of a neurological pheno-structure is not known. Experiments to determine the
type. It is likely that the transgene protein is being tar-crystal structure of this protein are in progress.
geted by ubiquitin for an eventually unsuccessful pro-A proposed mechanism for the fibril formation in-
teolytic breakdown. The covalent binding of ubiquitinduced by proteolytic cleavage of GST-HD51 is shown
occurs at lysine residues and would not impede polyglnin Figure 7. Based on the known crystal structure of
interactions. Strikingly, ultrastuctural analysis has shownGST with a C-terminal fusion peptide (Lim et al., 1994)
similar intranuclear inclusions to be present in the corti-and the fact that the purified GST protein is a dimer, we
cal and striatal biopsy material from HD patients (Roizinsuppose that native GST-HD51 exists as a dimer with
et al., 1979), some of which showed clear evidence oftwo expanded polygln sequences that form stable hair-
intranuclear fibrils of up to 1 mm in length. More recently,pins consisting of antiparallel b strands strongly held
NIIs have been identified in HD post mortem brain mate-together by hydrogen bonds between the main chain
rial by both immunocytochemistry with N-terminal HDand the side chain amides. In the native protein, both
antibodies and electron microscopy (M. DiFiglia, unpub-hairpins are tightly bound to the surface of GST and not
lished data). Preliminary experiments in our laboratoryaccessible for protein±protein interactions with other
with nuclear protein fractions prepared from HD brain
polygln sequences. As a result of the cleavage with a
material indicated that insoluble huntingtin aggregates
site-specific protease, both hairpins become accessible
are indeed present in these fractions (E. E. Wanker,
and b sheets with hairpins from other cleaved protein
unpublished data). However, additional control ex-
molecules are formed. This transient population of inter-
periments have to be performed to substantiate these
mediates consisting of GST molecules and hairpins
results.
leads to the formation of polygln-containing b sheet One possible explanation for the absence to date of
fibrils and free GST molecules. This model is supported high molecular weight huntingtin protein aggregates in
by the finding of potential intermediate structures pres- HD brains on immunoblots could be that the aggregates
ent on one or both ends of the growing fibrils (Figures 4c consist mainly of polygln-containing peptides that have
and 4d). These clots of varying sizes were not detected been cleaved from the full-length protein. In such a case,
when GST-HD51 was digested to completion with tryp- only an antibody raised against an N-terminal huntingtin
sin, which totally degrades the GST tag, while they were fragment, containing the polgln sequence, would be
detectable upon limited digestion, leaving the GST moi- able to detect the aggregates in the nucleus. In most of
ety largely intact (Figure 4d). This indicates that these the previous immunohistochemical studies, antibodies
structures are transient intermediates. raised against the central or C-terminal portion of hun-
A model of the formation of amyloid-like fibrils via tingtin have beenused, that detect the full-length protein
transient intermediates is not without precedent. Booth (350 kDa) in the cytosol and in the membrane containing
et al. (1997) have shown that amyloidogenic lysosome fractions (DiFiglia et al., 1995; Sharp et al., 1995; Trottier
variants aggregate on heating, unlike the wild-type pro- et al., 1995a). However, antibodies raised against pep-
tein, and that the lysozyme fibrils are formed from poten- tides and fusion proteins from the N and C termini of
tial precursor proteins. It is possible that the transient huntingtin also detected the protein in the nucleus
GST-HD intermediates function as nuclei for ordered (Hoogeveen et al., 1993; de Rooij et al., 1996), indicating
protein aggregation, very similarly to protein crystalliza- that huntingtin is also present in this subcellular com-
tion and microtubule formation, which are nucleation- partment. There are several lines of evidence to impli-
dependent polymerizations (Jarrett and Lansburry, 1993). cate a shorter polygln-containing peptide/protein frag-
Once a nucleus is formed, the further addition of mono- ment of huntingtin in the pathology of HD. Ikeda et al.
mers becomes thermodynamically favorable and results (1996) showed that a short fragment of the MJD1 protein
in rapid polymerization. An important feature of a nucle- containing 79 polyglns (Q79C) but not the full-length
ation-dependent process is a lag time before the aggre- protein with the elongated repeat induced apoptotic cell
gates are detectable. During this period, dimers and death in COS cells. The polygln-containing protein frag-
trimers are formed. Figure 3a shows that during proteo- ment migrated in SDS gels at a position much higher
lytic cleavage of GST-HD51, dimers of the released HD than expected from its molecular weight, even after boil-
portion are formed, the concentration of which then de- ing in the presence of 2% SDS. These results are in
creases upon prolonged incubation concomitant with good agreement with our data obtained using the GST-
an increase in the formation of large protein aggregates HD fusion proteins containing elongated polygln se-
quences. Figures 1a and 1b show that the expression(Figure 3b).
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and SalI, and inserted into the BamHI±SalI site of the expressionof GST-HD83 and GST-HD122 in E. coli was dramatically
vector pGEX-5X-1 (Pharmacia), yielding pCAG30, pCAG51, pCAG83,reduced compared to the fusion proteins containing
and pCAG122, respectively. pCAG20, containing 20 repeats of CAG20±51 repeats, and additional studies have indicated
within the cloned HD exon 1 sequence, was similarily constructed
that the elongated glutamines are toxic for E. coli cells. from a phage genomic clone derived from a normal allele. All con-
Our results confirm the experiments of Onodera et al. structs were verified by sequencing.
(1996), who determined that GST fusion proteins with
Purification of GST Fusion Proteins59±81 glutamines inhibit both cell growth and protein
E. coli SCS1 (Stratagene) carrying the pGEX expression plasmid ofsynthesis in E. coli, whereas the expression of proteins
interest was grown to an OD600 of 0.6 and induced with IPTG (1 mM)with less than 35±40 glutamines had little or no effect.
for 3.5 hr as described in the manufacturer's protocol (Pharmacia).
The possibility that polygln-containing cleavage prod- Cultures (200 ml) of induced bacteria were centrifuged at 4000 g
ucts of huntingtin cause neurodegeneration in HD is for 20 min, and the resulting pellets were stored at 2808C. Cells
substantiated by the finding of Goldberg et al. (1996), were thawed on ice and resuspended in 5 ml of lysis buffer (50 mM
sodium phosphate, 150 mM NaCl, 1 mM EDTA [pH 7.4]) containingwho showed that an N-terminal 80 kDa huntingtin frag-
0.5 mg/ml lysozyme. After 45 min at 08C, cells were sonicated withment is cleaved from the full-length protein by apopain,
two 30-sec bursts. Octyl-b-D-glucopyranoside was then added toa proapoptotic cysteine protease. This indicates that
a final concentration of 0.1% and the resulting lysate was clarified
the N terminus of huntingtin is primarily accessible for by centrifugation at 30,000 g for 30 min at 48C. Cleared lysates were
proteases and that distinct proteolytic cleavage prod- incubated for 1 hr at 48C with 500 ml of 1:1 slurry of glutathione-
ucts can be formed in vitro and in vivo. In addition, there agarose beads (Sigma) that had been washed three timesand resus-
pended in lysis buffer. The beads were poured into a small columnis strong evidence that the mutated huntingtin somehow
and washed extensively with lysis buffer containing 0.1% octyl-b-induces apoptotic cell death in HD, but the underlying
D-glucopyranoside. The bound fusion protein was eluted with 2 mlmolecular mechanism is not known (Duyao et al., 1995;
of 15 mM glutathione (reduced) in lysis buffer. Typical yields were
Portera-Cailliau et al., 1995). Our data suggest that a 0.5±1 mg of purified GST-HD20, -HD30, and -HD51 proteins per 200
proteolytic cleavage product of huntingtin, which is ml of bacterial culture; yields of GST-HD83 and -HD122 were much
transported into the nucleus by an unknownmechanism, lower, less than 10% of that obtained with the shorter fusion pro-
teins. Protein was determined by the Bio-Rad dye binding assaycauses selective neuronal cell death by the formation
using bovine serum albumin as standard.of insoluble amyloid-like fibrils. It is possibile that the
transport to the nucleus is facilitated by a specific nu-
Antibodies and Immunoblotting
clear transport mechanism that is unique to certain neu- A bacterial plasmid encoding HD1-His, a His6-tagged fusion protein
ronal cells and involves abnormal protein±protein inter- containing residues 1±222 of huntingtin, was generated by inserting
actions related to the elongated polygln. Alternatively, a PCR-amplified IT-15 cDNA fragment into the pQE-32 vector (Qia-
gen). The fusion protein was expressed in E. coli, affinity-purifiedthere may be specific nuclear proteins in the affected
under denaturating conditions on Ni-NTA agarose, and injected intoneurons that enhance the huntingtin protein aggre-
rabbits. The resulting immune serum was then affinity-purifiedgation.
against the antigen that had been immobilized on Ni-NTA agarose.The development of our in vitro model utilizing the
The GAPDH- and Fos B±specific antisera have been described (Da-
GST-HD fusion proteins could potentially open up new vies et al., 1997; Wanker et al., 1997).
avenues for therapeutic interventions. In the event that Western blotting was performed as detailed (Towbin et al., 1979).
The blots were incubated with 1:1000 dilutions of the indicatedthe formation of polygln-containing amyloid-like fibrils
primary antibody, followed by an alkaline-phosphatase-conjugatedproves to be the cause of HD, an inhibition of this pro-
secondary antibody. Color development was carried out withcess either directly or indirectly should prevent neuronal
5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium ascell death. The in vitro system allows the basic screening
substrates (Promega).
of a large number of potential therapeutic molecules
and should enable us to isolate specific agents that Site-Specific Cleavage of Fusion Proteins
inhibit the formation of polygln-containing polymers. The GST-HD fusion proteins purified as described above were dia-
lyzed against 40 mM Tris±HCl (pH 8.0), 150 mM NaCl, 0.1 mM EDTA,The ability of potential therapeutic agents arising from
and 5% (v/v) glycerol to raise the pH prior to proteolytic cleavage.this screen to prevent neuronal dysfunction and cell
The proteins were then combined with bovine factor Xa (New En-death could then be tested in the HD animal model.
gland Biolabs) or modified trypsin (Boehringer Mannheim, sequenc-
ing grade) in dialysis buffer containing 2 mM CaCl2 at an en-
zyme:substrate ratio of 1:10 (w/w) or 1:40 (w/w), respectively.Experimental Procedures
Incubations with factor Xa were at 258C for 16 hr. Tryptic digestions
were performed at 378C for 3 or 16 hr as indicated. DigestionsPlasmid Construction
were terminated by the addition of PMSF to 1 mM. The degree ofLambda phage from stock 91974 (Sathasivam et al., 1997) were
proteolysis was determined by SDS±PAGE followed by staining withplated to give single plaques that were inoculated into 400 ml cul-
Coomassie blue or immunoblotting using anti-HD1 antibody.tures of E. coli XL1-Blue MRF9 (Stratagene) for DNA preparation.
The DNA sequence encoding the N-terminal portion of huntingtin
(exon 1), including the CAG repeats, was amplified by PCR using Filter Retardation Assay
Factor Xa or trypsin digestions of purified GST-HD fusion proteinsthe following pair of primers: ES 25 (TGGGATCCGCATGGCGACCCT
GGAAAAGCTGATGAAGG), corresponding to nt 315±343 of the HD (10 mg) were performed in a 20 ml reaction mixture as described
above. Reactions were terminated by adjusting the mixture to 2%gene (Huntington's Disease Collaborative Research Group, 1993)
and containing a BamHI site (underlined), and ES 26 (GGAGTCGACT SDS and 50 mM DTT. After heating at 1008C for 5 min, aliquots (0.5
ml) were diluted into 200 ml of 0.1% SDS and filtered through aCACGGTCGGTGCAGCGGCTCCTCAGC), corresponding to nt 516±
588 and containing a SalI site (underlined). Conditions for PCR were cellulose acetate membrane (Schleicher and Schuell, 0.2 mm pore
size) using a BRL dot blot filtration unit. Filters were washed withas described (Mangiarini et al., 1996). Due to instabiltity of the CAG
repeat during propagation in E. coli, DNA preparations from individ- water, and the SDS-insoluble aggregates retained on the filter de-
tected by incubation with the anti-HD1 antibody, followed by anual plaques yielded different sized PCR products. Fragments of
z320, 360, 480, and 590 bp were gel-purified, digested with BamHI anti-rabbit secondary antibody conjugated to alkaline phosphatase
Huntingtin Protein Aggregates
557
(Boehringer Mannheim).This assay was also used to detect hunting- grant ªHuntingtinand MJD1º and grants from theEuropean Commu-
nity, Hereditary Disease Foundation, Medical Research Council, andtin aggregates present in a nuclear fraction from the brain of an
R6/2 hemizygous mouse and littermate control (see preparation of Special Trustees of Guy's and St. Thomas's Hopitals.
nuclei below).
Received June 2, 1997; revised July 18, 1997.
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